Compare Moderna, Inc. (MRNA) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Teucrium Soybean Fund — how do they compare? Moderna, Inc. trades at $136.2 (market cap $54.14B), while Teucrium Soybean Fund trades at $27.66. The key difference: Teucrium Soybean Fund is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | SOYB | |
|---|---|---|
Market Cap | $54.14B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $174.38 | $27.84 |
52-Week Low | $22.36 | $21.46 |
Enterprise Value | $50.29B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $140.33, down 3.59% on the day, amid mixed signals. The stock has seen volatility, with a 143% surge over the past month driven by positive cancer vaccine trial results (Fox Business, 2026-09-06), but faces headwinds from declining revenue and persistent net losses. Technical analysis shows a bullish overall signal, with support at $138 and resistance at $145, while fundamentals reveal a challenging profit margin of -142.58% for 2026.
The outlook hinges on pipeline successes, particularly in oncology, but high valuation ratios and competitive pressures pose risks. Analyst consensus is cautious, with a $90.08 price target, reflecting skepticism despite recent clinical milestones. Investors should weigh innovation potential against financial sustainability and market sentiment shifts.
SOYB trades at $27.84, up 0.69% today, with a bullish technical signal from moving averages but bearish oscillators. The stock shows strong momentum indicators, with RSI levels indicating overbought conditions. Recent news highlights commodity price trends influencing agricultural stocks.
The outlook remains tied to commodity market dynamics, with potential upside from rising soybean prices but risks from geopolitical tensions and volatility. Investors should weigh technical overbought signals against fundamental growth catalysts in the agricultural sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
